局部晚期宫颈癌放射学分期IVA期内镜评估:支持循证分期算法提案的双变量Meta分析
本研究通过系统检索和双变量Meta分析评估CT和MRI对局部晚期宫颈癌膀胱/直肠侵犯的预测价值,共纳入19项研究。膀胱侵犯汇总阳性预测值为45%(95%CI 33%-57%),直肠侵犯为30%(95%CI 17%-47%);两者阴性预测值分别达98%和100%。作者认为放射学分期阳性预测值低(<50%),内镜可能有必要用于正确评估放射学IVA期,但放射学阴性后则不必行内镜。
要点
- 膀胱侵犯汇总阳性预测值45%(95%CI 33%-57%),直肠侵犯30%(95%CI 17%-47%)。
- 膀胱侵犯和直肠侵犯汇总阴性预测值分别为98%(95%CI 97%-99%)和100%(95%CI 99%-100%)。
- 放射学阴性后阴性预测值≥95%,内镜可能并非必要;放射学阳性时阳性预测值<50%,内镜可能有必要。
核心结论
- 放射学分期阳性预测值低(<50%),内镜可能有必要用于正确评估放射学IVA期局部晚期宫颈癌。
- 放射学检查阴性后(阴性预测值≥95%),内镜可能并非必要。
研究设计与样本
- 系统检索PubMed和EMBASE数据库(注册号CRD42021270329)的系统评价与双变量Meta分析。
- 纳入标准包括宫颈癌诊断、分期CT和/或MRI(指标试验)、分期膀胱镜和/或直肠镜(标准试验)以及提供真阳性、真阴性、假阳性和假阴性数量。
- 共纳入19项研究,膀胱分析3480例患者,直肠分析1641例患者。
- 对阳性预测值和阴性预测值进行随机效应双变量Meta分析,并按影像学方法(CT和MRI)及患病率进行调节分析。
主要发现
- 膀胱侵犯患病率范围为0.9%至34.5%,汇总阳性预测值为45%(95%CI 33%-57%,基于19项研究)。
- 膀胱侵犯亚组:MRI/患病率≤6%阳性预测值31%,CT/患病率≤6%为33%,CT/患病率>6%为69%。
- 直肠侵犯患病率范围为0.4%至20.0%,汇总阳性预测值为30%(95%CI 17%-47%,基于8项研究)。
- 直肠侵犯亚组:MRI/患病率≤1%阳性预测值36%,MRI/患病率>1%为17%,CT/患病率>1%为38%。
- 膀胱侵犯和直肠侵犯汇总阴性预测值分别为98%(95%CI 97%-99%)和100%(95%CI 99%-100%);考虑患病率和影像学方法后,膀胱侵犯阴性预测值点估计为95%至100%,直肠侵犯为99%至100%。
临床怎么用
- 作者认为,由于放射学分期阳性预测值低(<50%),内镜可能有必要用于正确评估放射学IVA期局部晚期宫颈癌。
- 作者认为,放射学检查阴性后(阴性预测值≥95%),内镜可能并非必要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To optimize the use of confirmatory endoscopic exams (cystoscopy/proctoscopy) in the staging of locally advanced cervical cancer (LACC), the present study evaluates the predictive value of radiological exams (CT and MRI) to detect bladder/rectum invasion. METHODS: A systematic search of databases (PubMed and EMBASE) was performed (CRD42021270329). The inclusion criteria were: a) cervix cancer diagnosis; b) staging CT and/or MRI (index test); c) staging cystoscopy and/or proctoscopy (standard test); and d) numbers of true positives (TP), true negatives (TN), false positives (FP), and false negatives (FN) provided. A random-effects bivariate meta-analysis of positive predictive value (PPV) and negative predictive value (NPV) was performed with moderator analyses by imaging modality (CT and MRI) and prevalence. RESULTS: Nineteen studies met the inclusion criteria, totaling 3480 and 1641 patients for bladder and rectum analyses, respectively. For bladder invasion (prevalence ranged from 0.9% to 34.5%), the overall PPV was 45% (95% confidence interval, 33%-57%, based on 19 studies). Per subgroup, the PPV was 31% for MRI/prevalence ≤6%, 33% for CT/prevalence ≤6%, and 69% for CT/prevalence >6%. For rectal invasion (prevalence ranged from 0.4% to 20.0%), the overall PPV was 30% (95% confidence interval, 17%-47%, based on 8 studies). Per subgroup, the PPV was 36% for MRI/prevalence ≤1%, 17% for MRI/prevalence >1%, and 38% for CT/prevalence >1%. The overall NPV for bladder invasion and rectal invasion were 98% (95% confidence interval, 97%-99%) and 100% (95% confidence interval, 99%-100%), respectively. Considering prevalence and radiological modality, the point estimate of NPV varied from 95% to 100% for bladder invasion and from 99% to 100% for rectum invasion. CONCLUSIONS: Due to low PPV (<50%) of radiological staging, endoscopic exams may be necessary to correctly assess radiological stage IVA LACC. However, they are not necessary after negative radiological exam (NPV ≥95%).
引用
- Sapienza LG, Thomas JJ, Showalter TN, et al. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal. Gynecol Oncol. 2022. PMID: 35410732. doi:10.1016/j.ygyno.2022.03.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。